Skip to main content
. 2021 Dec 1;37:100916. doi: 10.1016/j.ijcha.2021.100916

Fig. 4.

Fig. 4

Summary of the main findings of the meta-analysis. The 30-day risk of mortality, myocardial infarction, target vessel revascularization, or stroke were not different between HCR and PCI. However, There was a lower risk of myocardial infarction and target vessel revascularization during the follow-up for HCR in comparison with PCI. CI, confidence interval; HCR, hybrid coronary revascularization; OR, odds ratio; PCI, percutaneous coronary intervention.